Intratracheal instillation of antigen-pulsed macrophages mediates repression of allergic airway inflammation Source: Eur Respir J 2003; 22: Suppl. 45, 483s Year: 2003
Salbutamol attenuates nasal symptoms and mast cell degranulation by AMP challenge Source: Eur Respir J 2005; 26: Suppl. 49, 228s Year: 2005
Oral tolerance attenuates airway remodelling in a model of chronic allergic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 591s Year: 2006
Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats Source: Eur Respir J 2006; 27: 726-734 Year: 2006
Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice Source: Eur Respir J 2009; 34: 200-208 Year: 2009
Role of IL-33 signaling in pollutant-induced allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018
Absence of proton-sensing TDAG8 protects against ovalbumin-induced allergic airway inflammation Source: International Congress 2017 – New insights into pathogenesis of lung disease Year: 2017
Modulation of inflammatory cells apoptosis induced by oral tolerance in a model of chronic allergic airway inflammation in guinea pigs Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005
Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459 Source: Eur Respir J 2013; 41: 46-52 Year: 2013
Obesity enhances allergen-induced airway inflammation in a murine model of asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019
Oral presentation: The role of mast cells, IL-13 and TRP channels in a mouse model of chemical-induced airway hyperresponsiveness Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013
Oral presentation: The role of mast cells, IL-13 and TRP channels in a mouse model of chemical-induced airway hyperresponsiveness Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013
HIF-1α inhibitor, 2ME2, attenuates airway inflammation and hyperresponsiveness in allergic airway disease Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002
The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007
Involvement of NK1, 2 and 3 receptors on antigen-induced airway hyperresponsiveness and inflammation induced in guinea-pigs Source: Eur Respir J 2001; 18: Suppl. 33, 246s Year: 2001
Oral presentation: ILC2 contribute to ozone-induced airway hyperresponsiveness in obese mice Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014
Evidence for secretion of IL-18 in asthmatic airway inflammation assessed by endobronchial allergen challenge and its relationship to accumulation of inflammatory cells Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001
In vivo blockade of CTLA-4 counteracts inhalation tolerance and leads to development of allergic airway inflammation in mice repeatedly exposed to aerosolized ovalbumin Source: Eur Respir J 2004; 24: Suppl. 48, 6s Year: 2004
The PAR2 -activating peptide SLIGRL inhibits airway hyper-responsiveness and eosinophilia in an acute murine model of allergic asthma Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology Year: 2004